Cancer Health Treatment Update Immunotherapy Shows 100% Response Rate for Selected Rectal Cancer Patients In a small trial, Jemperli led to complete remission in people with a biomarker for deficient DNA repair. Many Black Patients With Metastatic Breast Cancer Are Not Told About Clinical Trials 40% of Black people with metastatic breast cancer were not informed about clinical trials, but 83% expressed interest in participating. COVID-19 Pandemic Increased Cancer-Related Deaths in U.S. Cancer-related deaths climbed 3.2% from 2019 to 2020, the first year of COVID-19, a new report shows. Alarming Rise in Esophageal Cancer Seen Among Middle-Aged Adults Rates of esophageal cancer and a precursor condition rose steeply between 2012 and 2019. Advertisement News From ASCO 2022 See all our reports from the American Society of Clinical Oncology annual meeting—the world's largest conference conference. Cancer Health now offers individual newsletters for people interested in specific cancer types. Get the latest cancer news tailored to your needs and interests delivered to your inbox. To update your preferences and start getting cancer-specific newsletters, please visit your personal preferences page. Depression, Loneliness Associated With Increased Hospitalization Risk After COVID-19 Women who reported chronic depression before the pandemic were 72% more likely to be hospitalized after COVID-19 diagnosis. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Spring 2022 Check out our latest print edition! Newsfeed Breast, Cervical and Colorectal Cancer Screenings Drop by Millions During COVID-19 CDC Awards $215M for Cancer Prevention and Moonshot Goals COVID-19 Pandemic Increased Cancer-Related Deaths in U.S. ASCO & WHO to Collaborate on Quality Indicators for Cancer Facilities Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Second-Line Treatment of Large B-cell Lymphoma FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia Newsfeed Breast, Cervical and Colorectal Cancer Screenings Drop by Millions During COVID-19 CDC Awards $215M for Cancer Prevention and Moonshot Goals COVID-19 Pandemic Increased Cancer-Related Deaths in U.S. ASCO & WHO to Collaborate on Quality Indicators for Cancer Facilities Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Second-Line Treatment of Large B-cell Lymphoma FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: